Skip to main content
MRK logo
MRK
(NYSE)
Merck & Co., Inc.
$150.33-- (--)
Loading... - Market loading

Merck & Co. (MRK) Stock Price & Financial Analysis

Merck & Co. Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$150.09 - $152.22
52-Week High$156.92
52-Week Low$77.58
Open$150.83
Volume4.17M
Average Volume (3M)9.68M
Market Cap371.62B
Shares Outstanding2.47B
P/E Ratio (TTM)41.59
Forward P/E81.83
Price to Sales (P/S)5.66
Price to Book (P/B)8.09
EV/EBITDA22.84
Revenue (TTM)65.69B
Net Income (TTM)8.94B
Free Cash Flow (TTM)14.12B
EPS (TTM)$3.58
Profit Margin13.60%
Operating Margin21.71%
Return on Equity (ROE)19.45%
Debt to Equity1.07
50-Day MA$134.59
200-Day MA$118.40
52-Week Change77.46%
Annual Dividend$3.36
Dividend Yield2.24%
Payout Ratio93.74%
Last Dividend Ex-DateSep 15, 2026

Frequently Asked Questions About Merck & Co.

What is the current stock price for MRK?

As of the latest trading session, MRK stock trades at $150.33. The 52-week range is $77.58–$156.92, with a day range of $150.09–$152.22.

What is the P/E ratio for MRK?

Merck & Co.'s trailing P/E ratio is 41.6, meaning investors pay $41.6 for every $1 of annual earnings. The forward P/E is 81.8, reflecting analyst expectations for future earnings. Merck & Co. operates in the Healthcare sector.

Does MRK pay dividends?

Yes, Merck & Co. pays a 2.24% annual dividend yield ($3.36 per share). The payout ratio is 93.7%. The last ex-dividend date was 2026-09-15.

What do analysts recommend for MRK?

Based on 37 analysts, the consensus for MRK is Buy.

What is the market cap of MRK?

Merck & Co.'s market capitalization is $371.62B, classifying it as a mega-cap company. Merck & Co. operates in the Healthcare sector within the Drug Manufacturers - General industry.